DDC and Parkinson disease: L-dopa is used widely to increase dopamine concentrations in the treatment of Parkinson's disease with a dopa decarboxylase inhibitor, such as carbidopa and benserazide, which inhibit aromatic amino acid decarboxylase, thus preventing the conversion of L-dopa into dopamine 49.